Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kgoglin
    Member
    • Dec 2014
    • 17

    #1

    Blue Pippen problems

    Is anyone else having problems with Blue Pippen's accuracy? Our error % from all our control DNAs tests range from 3-13%.

    One Example:
    Tight Setting(250bp)
    Bioanalyzer average size (bp) (282bp)
    12.8% error

    What is an acceptable error rate for the Blue Pippen?

    We have been using a 20bp offset for our samples (both amplicon and sheared gDNA) and BP control DNA. (So for a 390bp extraction, we use the 370bp tight setting.) This has been working for a while, but not anymore. We contacted Sage Science, who has been helping us a little, but we are still running through loops. Sage says our BP instrument log files are great and that it could be a cassette issue. They also think that since we are using PCR product, we may have single-stranded DNA that may be interfering with how we visualize peaks on the Bioanalzyer. This may be true but our sheared gDNA does not size accurately either.

    Sage Science suggests that, for every new sample type, we run a test run to determine the best setting. Does anyone do this?

    What other problems have you seen with the Blue Pippen? Is there a better alternative?
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    One has to take into account size distribution CV, reproducibility% and accuracy% for each Cassette type. Loading quantity, structure of DNA (blunt ended, Y shape, staggered ends) also can affect the size range distribution. On top of all of these also BA has its own specifications and deviation from them also will affect the sizing.

    Your example of tight setting at 370bp will collect fragments in 337-403bp. If you use range setting of 350-390 it will not collect 370bp as that setting is narrower than tightest setting possible for which the software gives a narrow warning.

    I agree with Sage explanation and their platform is much better than another one that I have tried.

    Comment

    • kerplunk412
      Senior Member
      • Jun 2012
      • 119

      #3
      I know that to select small RNA libraries of ~150 bp and exclude adapter-dimer at ~130 bp you must use settings way different from expected (115 bp-170 bp collection range), so I am not surprised that a little optimization may be necessary.

      Regarding a better alternative, the only other thing I have tried is the E-gel, and Pippin is so much better it isn't even a comparison. I think the Caliper LabChip is probably a better comparison but I haven't had a chance to try it. I did find this Googling a little though.

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        I had a similar result to the linked paper in kerplunk412 post comparing Pippin and LabChip.

        Comment

        • kgoglin
          Member
          • Dec 2014
          • 17

          #5
          Thank you for responding

          Sage Science said that they like to see less than 10% error from the control DNA. This seems pretty high to me but if that's the case, then I guess we will have to test more than one setting for each sample type.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 07:41 AM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...